Abstract Details

Title Neuroprotective Activity of Methylthioadenosine for the Treatment of Multiple Sclerosis and Other Neurological Diseases

Topic MS and Related Diseases

Presentation(s) (-)

Poster/Presentation
Number 003

Objective

Background

Design/Methods

Results

Conclusions

Authors/Disclosures
Pablo Villoslada, MD, PhD, FAAN (Hospital del Mar Research Institute)	Dr. Villoslada has received personal compensation for serving as an employee of Attune Neuroscience. Dr. Villoslada has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Accure Therapeutics. Dr. Villoslada has received personal compensation in the range of $10,000-$49,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Oculis. Dr. Villoslada has stock in Attune Neurosciences. Dr. Villoslada has stock in Bionure Investments. Dr. Villoslada has stock in Spiral Therapeutics. Dr. Villoslada has stock in Adhera Health. The institution of Dr. Villoslada has received research support from Start2Cure Foundation. The institution of Dr. Villoslada has received research support from NIH. The institution of Dr. Villoslada has received research support from Department of Defense. Dr. Villoslada has received intellectual property interests from a discovery or technology relating to health care.
	No disclosure on file
Martin Kerschensteiner, MD	No disclosure on file
	No disclosure on file
	No disclosure on file
	No disclosure on file
	No disclosure on file
	No disclosure on file
	No disclosure on file
	No disclosure on file
	No disclosure on file
	No disclosure on file
	No disclosure on file
Jack M. Parent, MD (University of Michigan)	No disclosure on file
	No disclosure on file
	No disclosure on file
Jordi Serra, MD (Clinica Sagrada Familia)	No disclosure on file
	No disclosure on file
	No disclosure on file

��ɫ��

��ɫ��

Abstract Details

��ɫ����

��ɫ����

��ɫ��

��ɫ��